Evaluation Of the Protective Effects of Coenzyme Q10, Vitamin E, And Their Combination Against Simvastatin-Induced Myopathy in Male Rats (An Immunohistochemistry Study)

One of the significant adverse effects of statin medication is simvastatin-induced myopathy, for which there are few effective preventative measures. Simvastatin-induced skeletal muscle myopathy in male rats was assessed in this study utilizing immunohistochemical analysis of BAX (BCL2-associated protein X) expression to determine the preventive effects of Coenzyme Q10, Vitamin E, and their combination. After being divided into groups, the rats were given simvastatin, Coenzyme Q10, vitamin E, or all three together for 30 days. The treatment groups' levels of BAX expression, a marker of apoptosis, were considerably lower than those of the group taking simvastatin alone. The biggest reduction was seen with the combination treatment, with an average immunohistochemistry (IHC) -intensity score of 1.0 ± 0.577, whereas the induction group's score was 2.857 ± 0.378. These results demonstrated the ability of vitamin E and Coenzyme Q10, particularly when combined, to reduce statin-induced muscle apoptosis. Future suggested treatment approaches to stop myopathy in statin users are based on the findings.